149 related articles for article (PubMed ID: 25366275)
1. Preliminary functional assessment and classification of DEPDC5 variants associated with focal epilepsy.
van Kranenburg M; Hoogeveen-Westerveld M; Nellist M
Hum Mutat; 2015 Feb; 36(2):200-9. PubMed ID: 25366275
[TBL] [Abstract][Full Text] [Related]
2. Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.
Weckhuysen S; Marsan E; Lambrecq V; Marchal C; Morin-Brureau M; An-Gourfinkel I; Baulac M; Fohlen M; Kallay Zetchi C; Seeck M; de la Grange P; Dermaut B; Meurs A; Thomas P; Chassoux F; Leguern E; Picard F; Baulac S
Epilepsia; 2016 Jun; 57(6):994-1003. PubMed ID: 27173016
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy.
Ricos MG; Hodgson BL; Pippucci T; Saidin A; Ong YS; Heron SE; Licchetta L; Bisulli F; Bayly MA; Hughes J; Baldassari S; Palombo F; ; Santucci M; Meletti S; Berkovic SF; Rubboli G; Thomas PQ; Scheffer IE; Tinuper P; Geoghegan J; Schreiber AW; Dibbens LM
Ann Neurol; 2016 Jan; 79(1):120-31. PubMed ID: 26505888
[TBL] [Abstract][Full Text] [Related]
4. mTOR signaling pathway genes in focal epilepsies.
Baulac S
Prog Brain Res; 2016; 226():61-79. PubMed ID: 27323939
[TBL] [Abstract][Full Text] [Related]
5. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.
Scheffer IE; Heron SE; Regan BM; Mandelstam S; Crompton DE; Hodgson BL; Licchetta L; Provini F; Bisulli F; Vadlamudi L; Gecz J; Connelly A; Tinuper P; Ricos MG; Berkovic SF; Dibbens LM
Ann Neurol; 2014 May; 75(5):782-7. PubMed ID: 24585383
[TBL] [Abstract][Full Text] [Related]
6. DEPDC5 mutations in familial and sporadic focal epilepsy.
Tsai MH; Chan CK; Chang YC; Yu YT; Chuang ST; Fan WL; Li SC; Fu TY; Chang WN; Liou CW; Chuang YC; Ng CC; Hwang DY; Lim KS
Clin Genet; 2017 Oct; 92(4):397-404. PubMed ID: 28170089
[TBL] [Abstract][Full Text] [Related]
7. Depdc5 knockout rat: A novel model of mTORopathy.
Marsan E; Ishida S; Schramm A; Weckhuysen S; Muraca G; Lecas S; Liang N; Treins C; Pende M; Roussel D; Le Van Quyen M; Mashimo T; Kaneko T; Yamamoto T; Sakuma T; Mahon S; Miles R; Leguern E; Charpier S; Baulac S
Neurobiol Dis; 2016 May; 89():180-9. PubMed ID: 26873552
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic features of GATOR1 complex-associated epilepsy.
Yin K; Lei X; Yan Z; Yang Y; Deng Q; Lu Q; Zhang X; Wang M; Liu Q
J Med Genet; 2023 Aug; 60(8):784-790. PubMed ID: 36604176
[TBL] [Abstract][Full Text] [Related]
9. DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.
Iffland PH; Baybis M; Barnes AE; Leventer RJ; Lockhart PJ; Crino PB
Neurobiol Dis; 2018 Jun; 114():184-193. PubMed ID: 29481864
[TBL] [Abstract][Full Text] [Related]
10. Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hoogeveen-Westerveld M; Ekong R; Povey S; Mayer K; Lannoy N; Elmslie F; Bebin M; Dies K; Thompson C; Sparagana SP; Davies P; van Eeghen AM; Thiele EA; van den Ouweland A; Halley D; Nellist M
Hum Mutat; 2013 Jan; 34(1):167-75. PubMed ID: 22903760
[TBL] [Abstract][Full Text] [Related]
11. SZT2 dictates GATOR control of mTORC1 signalling.
Peng M; Yin N; Li MO
Nature; 2017 Mar; 543(7645):433-437. PubMed ID: 28199315
[TBL] [Abstract][Full Text] [Related]
12. Acute knockdown of Depdc5 leads to synaptic defects in mTOR-related epileptogenesis.
De Fusco A; Cerullo MS; Marte A; Michetti C; Romei A; Castroflorio E; Baulac S; Benfenati F
Neurobiol Dis; 2020 Jun; 139():104822. PubMed ID: 32113911
[TBL] [Abstract][Full Text] [Related]
13. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
[TBL] [Abstract][Full Text] [Related]
14. DEPDC5 as a potential therapeutic target for epilepsy.
Myers KA; Scheffer IE
Expert Opin Ther Targets; 2017 Jun; 21(6):591-600. PubMed ID: 28406046
[TBL] [Abstract][Full Text] [Related]
15. Amino acid deprivation inhibits TORC1 through a GTPase-activating protein complex for the Rag family GTPase Gtr1.
Panchaud N; Péli-Gulli MP; De Virgilio C
Sci Signal; 2013 May; 6(277):ra42. PubMed ID: 23716719
[TBL] [Abstract][Full Text] [Related]
16. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy.
Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ
Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411
[TBL] [Abstract][Full Text] [Related]
17. What is the impact of a novel DEPDC5 variant on an infant with focal epilepsy: a case report.
Gu C; Lu X; Ma J; Pu L; Zhi X; Shu J; Li D; Cai C
BMC Pediatr; 2022 Jul; 22(1):459. PubMed ID: 35907814
[TBL] [Abstract][Full Text] [Related]
18. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population.
Martin C; Meloche C; Rioux MF; Nguyen DK; Carmant L; Andermann E; Gravel M; Cossette P
Clin Genet; 2014 Dec; 86(6):570-4. PubMed ID: 24283814
[TBL] [Abstract][Full Text] [Related]
19. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy.
Ribierre T; Deleuze C; Bacq A; Baldassari S; Marsan E; Chipaux M; Muraca G; Roussel D; Navarro V; Leguern E; Miles R; Baulac S
J Clin Invest; 2018 Jun; 128(6):2452-2458. PubMed ID: 29708508
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility.
Yuskaitis CJ; Jones BM; Wolfson RL; Super CE; Dhamne SC; Rotenberg A; Sabatini DM; Sahin M; Poduri A
Neurobiol Dis; 2018 Mar; 111():91-101. PubMed ID: 29274432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
